OCU-410

N/A

Report date: 2024/03/19 15:36:24

Base Information

Drug NameOCU-410
Drug Alias NameAAV-RORAOCU-410
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV5 vector
Mechanisms of ActionNuclear receptor ROR-alpha gene transference
TargetsNuclear receptor ROR-alpha
Therapy Area/IndicationsGeographic AtrophyMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSchepens Eye Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesOcugen Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A